annual current liabilities:
$27.23B+$386.65M(+1.44%)Summary
- As of today (May 21, 2025), GSK annual total current liabilities is $27.23 billion, with the most recent change of +$386.65 million (+1.44%) on December 31, 2024.
- During the last 3 years, GSK annual current liabilities has fallen by -$4.72 billion (-14.78%).
- GSK annual current liabilities is now -24.18% below its all-time high of $35.91 billion, reached on December 31, 2017.
Performance
GSK Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$26.95B-$275.91M(-1.01%)Summary
- As of today (May 21, 2025), GSK quarterly total current liabilities is $26.95 billion, with the most recent change of -$275.91 million (-1.01%) on March 31, 2025.
- Over the past year, GSK quarterly current liabilities has increased by +$1.89 billion (+7.56%).
- GSK quarterly current liabilities is now -41.27% below its all-time high of $45.89 billion, reached on June 30, 2022.
Performance
GSK quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
GSK Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.4% | +7.6% |
| 3 y3 years | -14.8% | -15.5% |
| 5 y5 years | -13.7% | -14.0% |
GSK Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.8% | +1.4% | -41.3% | +15.2% |
| 5 y | 5-year | -14.8% | +1.4% | -41.3% | +15.2% |
| alltime | all time | -24.2% | +4815.1% | -41.3% | +3049.9% |
GSK Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $26.95B(-1.0%) |
| Dec 2024 | $27.23B(+1.4%) | $27.23B(-5.2%) |
| Sep 2024 | - | $28.72B(+11.6%) |
| Jun 2024 | - | $25.73B(+2.7%) |
| Mar 2024 | - | $25.06B(-6.6%) |
| Dec 2023 | $26.84B(-2.8%) | $26.84B(-1.8%) |
| Sep 2023 | - | $27.32B(-2.0%) |
| Jun 2023 | - | $27.89B(+8.8%) |
| Mar 2023 | - | $25.63B(-7.1%) |
| Dec 2022 | $27.60B(-13.6%) | $27.60B(+18.0%) |
| Sep 2022 | - | $23.40B(-49.0%) |
| Jun 2022 | - | $45.89B(+43.9%) |
| Mar 2022 | - | $31.89B(-0.2%) |
| Dec 2021 | $31.95B(+5.8%) | $31.95B(+6.1%) |
| Sep 2021 | - | $30.10B(+1.7%) |
| Jun 2021 | - | $29.60B(+6.2%) |
| Mar 2021 | - | $27.87B(-7.7%) |
| Dec 2020 | $30.18B(-4.3%) | $30.18B(+5.8%) |
| Sep 2020 | - | $28.53B(-3.1%) |
| Jun 2020 | - | $29.45B(-6.0%) |
| Mar 2020 | - | $31.34B(-0.6%) |
| Dec 2019 | $31.53B(+10.5%) | $31.53B(+0.5%) |
| Sep 2019 | - | $31.36B(-4.0%) |
| Jun 2019 | - | $32.67B(+2.4%) |
| Mar 2019 | - | $31.90B(+11.8%) |
| Dec 2018 | $28.54B(-20.5%) | $28.54B(+19.1%) |
| Sep 2018 | - | $23.97B(+0.7%) |
| Jun 2018 | - | $23.79B(-37.0%) |
| Mar 2018 | - | $37.74B(+5.1%) |
| Dec 2017 | $35.91B(+53.8%) | $35.91B(-2.6%) |
| Sep 2017 | - | $36.85B(-1.6%) |
| Jun 2017 | - | $37.45B(+60.0%) |
| Mar 2017 | - | $23.40B(+0.3%) |
| Dec 2016 | $23.34B(+17.4%) | $23.34B(-0.7%) |
| Sep 2016 | - | $23.51B(-3.5%) |
| Jun 2016 | - | $24.38B(+21.9%) |
| Mar 2016 | - | $20.00B(+0.6%) |
| Dec 2015 | $19.88B(-3.9%) | $19.88B(+2.9%) |
| Sep 2015 | - | $19.32B(-10.9%) |
| Jun 2015 | - | $21.69B(-7.2%) |
| Mar 2015 | - | $23.38B(+13.0%) |
| Dec 2014 | $20.69B(-8.2%) | $20.69B(-16.6%) |
| Sep 2014 | - | $24.80B(+18.8%) |
| Jun 2014 | - | $20.87B(+7.5%) |
| Mar 2014 | - | $19.42B(-13.9%) |
| Dec 2013 | $22.55B(+1.0%) | $22.55B(+8.7%) |
| Sep 2013 | - | $20.74B(+9.0%) |
| Jun 2013 | - | $19.03B(+4.3%) |
| Mar 2013 | - | $18.25B(-18.3%) |
| Dec 2012 | $22.33B(-3.5%) | $22.33B(-1.5%) |
| Sep 2012 | - | $22.66B(-5.2%) |
| Jun 2012 | - | $23.90B(+3.1%) |
| Mar 2012 | - | $23.19B(+0.3%) |
| Dec 2011 | $23.13B(+17.1%) | $23.13B(+13.2%) |
| Sep 2011 | - | $20.44B(-6.6%) |
| Jun 2011 | - | $21.89B(+3.9%) |
| Mar 2011 | - | $21.07B(+6.7%) |
| Dec 2010 | $19.75B | $19.75B(+11.2%) |
| Sep 2010 | - | $17.76B(-1.0%) |
| Jun 2010 | - | $17.93B(-2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $18.45B(-5.9%) |
| Dec 2009 | $19.60B(+33.6%) | $19.60B(+10.1%) |
| Sep 2009 | - | $17.79B(+19.6%) |
| Jun 2009 | - | $14.87B(+6.4%) |
| Mar 2009 | - | $13.98B(-4.7%) |
| Dec 2008 | $14.67B(-28.7%) | $14.67B(-6.4%) |
| Sep 2008 | - | $15.67B(-4.8%) |
| Jun 2008 | - | $16.47B(-10.5%) |
| Mar 2008 | - | $18.41B(-10.5%) |
| Dec 2007 | $20.57B(+44.6%) | $20.57B(+11.4%) |
| Sep 2007 | - | $18.46B(+27.6%) |
| Jun 2007 | - | $14.47B(-1.2%) |
| Mar 2007 | - | $14.64B(+3.0%) |
| Dec 2006 | $14.22B(-13.0%) | $14.22B(+4.2%) |
| Sep 2006 | - | $13.65B(-10.4%) |
| Jun 2006 | - | $15.24B(-6.1%) |
| Mar 2006 | - | $16.24B(-0.7%) |
| Dec 2005 | $16.35B(+1.4%) | $16.35B(-1.7%) |
| Sep 2005 | - | $16.64B(+1.7%) |
| Jun 2005 | - | $16.37B(-5.2%) |
| Mar 2005 | - | $17.27B(+7.0%) |
| Dec 2004 | $16.13B(+5.1%) | $16.13B(+26.9%) |
| Sep 2004 | - | $12.71B(-10.6%) |
| Jun 2004 | - | $14.22B(-11.3%) |
| Mar 2004 | - | $16.04B(+4.5%) |
| Dec 2003 | $15.35B(+8.1%) | $15.35B(+10.1%) |
| Sep 2003 | - | $13.95B(+5.2%) |
| Jun 2003 | - | $13.26B(-0.8%) |
| Mar 2003 | - | $13.37B(-5.9%) |
| Dec 2002 | $14.20B(+3.7%) | $14.20B(+1.2%) |
| Sep 2002 | - | $14.03B(-7.4%) |
| Jun 2002 | - | $15.15B(+11.9%) |
| Mar 2002 | - | $13.54B(-1.1%) |
| Dec 2001 | $13.69B(+1.1%) | $13.69B(+2.8%) |
| Sep 2001 | - | $13.32B(+7.5%) |
| Jun 2001 | - | $12.39B(-9.7%) |
| Mar 2001 | - | $13.72B(+1.3%) |
| Dec 2000 | $13.54B(+59.3%) | $13.54B(+5.5%) |
| Sep 2000 | - | $12.83B(-2.3%) |
| Jun 2000 | - | $13.14B(-1.2%) |
| Mar 2000 | - | $13.30B(+56.3%) |
| Dec 1999 | $8.50B(+24.1%) | $8.50B(+19.0%) |
| Jun 1999 | - | $7.15B(+4.2%) |
| Dec 1998 | $6.86B(+6.5%) | $6.86B(+16.4%) |
| Jun 1998 | - | $5.89B(-8.5%) |
| Dec 1997 | $6.44B(-8.8%) | $6.44B(-8.8%) |
| Dec 1996 | $7.06B(-16.7%) | $7.06B(+39.7%) |
| Dec 1995 | $8.48B(+67.8%) | - |
| Jun 1995 | - | $5.05B(+54.0%) |
| Jun 1995 | $5.05B(+54.0%) | - |
| Jun 1994 | $3.28B(-1.1%) | $3.28B(-1.1%) |
| Jun 1993 | $3.32B(+11.4%) | $3.32B(+11.4%) |
| Jun 1992 | $2.98B(-9.4%) | $2.98B(-9.4%) |
| Jun 1991 | $3.29B(+34.2%) | $3.29B(+34.2%) |
| Jun 1990 | $2.45B(+83.2%) | $2.45B(+83.2%) |
| Jun 1989 | $1.34B(-9.9%) | $1.34B(-9.9%) |
| Jun 1988 | $1.48B(+29.7%) | $1.48B(+29.7%) |
| Jun 1987 | $1.14B(+33.8%) | $1.14B(+33.8%) |
| Jun 1986 | $855.56M(+52.6%) | $855.56M |
| Jun 1985 | $560.59M(+1.2%) | - |
| Jun 1984 | $553.91M | - |
FAQ
- What is GSK annual total current liabilities?
- What is the all time high annual current liabilities for GSK?
- What is GSK annual current liabilities year-on-year change?
- What is GSK quarterly total current liabilities?
- What is the all time high quarterly current liabilities for GSK?
- What is GSK quarterly current liabilities year-on-year change?
What is GSK annual total current liabilities?
The current annual current liabilities of GSK is $27.23B
What is the all time high annual current liabilities for GSK?
GSK all-time high annual total current liabilities is $35.91B
What is GSK annual current liabilities year-on-year change?
Over the past year, GSK annual total current liabilities has changed by +$386.65M (+1.44%)
What is GSK quarterly total current liabilities?
The current quarterly current liabilities of GSK is $26.95B
What is the all time high quarterly current liabilities for GSK?
GSK all-time high quarterly total current liabilities is $45.89B
What is GSK quarterly current liabilities year-on-year change?
Over the past year, GSK quarterly total current liabilities has changed by +$1.89B (+7.56%)